Physicians at a California stem cell clinic have urged the Supreme Court to review a federal appeals court decision holding that the FDA has the authority to regulate stem cells as drugs. The petitioners asserted that the agency has no authority over a stem cell procedure used by the clinic (California Stem Cell Treatment Center, Inc. v. United States, No. 24-1189 (U.S.)). In... Read More